Dr. Wang is a faculty member in the Center for Biostatistics and Qualitative Methodology at the University of Pittsburgh. She collaborates with clinical investigators on the design, conduct, monitoring, analysis, and interpretation of clinical trials and patient-oriented studies. Her methodological interests include longitudinal data analysis, survival and competing-risks analysis, methods for handling missing data, and measurement invariance. Her current collaborative work spans cardiology, gastroenterology, and palliative care, as well as projects with investigators at VA Pittsburgh aimed at improving Veterans' health. She also contributes to graduate education through the Institute for Clinical Research Education and mentors trainees and early-career investigators. Before returning to Pitt in 2023, she served as an instructor and collaborative biostatistician at the University of Illinois Chicago.
Dr. Wang's academic path began in chemistry and biochemistry before she transitioned to biostatistics. Outside of work, she enjoys spending time with her family.
Education & Training
- BS (Chemistry), Jilin University, 2005
- MS (Biochemistry), Purdue University, 2009
- PhD (Biostatistics), University of Pittsburgh, 2015
- Postdoctoral Fellowship (Biostatistics), University of Pittsburgh, 2016
Representative Publications
Chinman M, Wang T, Dodge JR, Frank DA, McCoy JL, Cohen AN. Tailored weight loss programs for adults with serious mental illness: A randomized clinical trial. JAMA Psychiatry. 2026; 83(2):139-148.
This randomized clinical trial evaluated CoachToFit, a six-month technology-supported weight-loss program with peer-specialist coaching for Veterans with serious mental illness. At six months, participants assigned to CoachToFit lost more weight on average than those receiving usual care, and the intervention showed potential as a tailored approach for this population.
Schenker Y, Belin SC, Wang T, et al. Facilitated versus patient-directed advance care planning among patients with advanced cancer: A randomized clinical trial. JCO Oncol Pract. 2025; 21(10):1447-1457.
This randomized comparative-effectiveness trial found that nurse-facilitated advance care planning produced greater patient engagement and higher advance-directive completion than patient-directed written and web-based materials. Both approaches increased advance care planning behaviors from baseline.
Snitz BE, Wang T, Cloonan YK, Jacobsen E, Chang CH, Hughes TF, Kamboh MI, Ganguli M. Risk of progression from subjective cognitive decline to mild cognitive impairment: The role of study setting. Alzheimers Dement. 2018; 14(6):734-742.
This study found that the risk of progression from subjective cognitive decline (SCD) to mild cognitive impairment (MCI) was higher in a speciality memory clinic than in a population-based study. Thus, study setting should be considered carefully when evaluating SCD as a risk state for MCI or dementia.
Click here for a more complete bibliography of Dr. Wang's work.
Research Interests
- Clinical trial design and analysis
- Survival analysis with a focus on accommodating competing risks
- Longitudinal data analysis
- Missing-data methods
- Measurement invariance